Many studies have shown that pro-inflammatory cytokines and chemokines such as TNF-α, IL-6, MCP-1, and IL-1β in the liver play key roles in the progression of metabolic diseases [37,38,39,40]. The gene discussed is CCL2; the disease is metabolic disease.